GAMP-5 Risk Based Continuous DevOps

•Download as PPTX, PDF•

1 like•619 views

George Georgalis

This document discusses applying principles from GAMP-5, which provides guidance for quality assurance in pharmaceutical manufacturing, to development operations using agile and continuous deployment methods. It proposes taking a risk-based approach to ensure compliance and readiness when using agile and continuous deployment practices for software development and operations.

GAMP-5 Risk Based Agile
Continuous Deployment
& Quality Integration
An Evolution From
Traditional IT Operations
Applying the "Good Automated Manufacturing Process"
Guidance from Pharma to traditional DevOps SDLS
For Agile, Continuous Operations.
A Risk Based approach to compliance and readiness.
George Georgalis <george@galis.org>

GAMP-5 Risk Based Continuous DevOps

GAMP-5 Risk Based Continuous DevOps

GAMP-5 Risk Based Continuous DevOps

GAMP-5 Risk Based Continuous DevOps

GAMP-5 Risk Based Continuous DevOps

GAMP-5 Risk Based Continuous DevOps

GAMP-5 Risk Based Continuous DevOps

GAMP-5 Risk Based Continuous DevOps

GAMP-5 Risk Based Continuous DevOps

GAMP-5 Risk Based Continuous DevOps

GAMP-5 Risk Based Continuous DevOps

GAMP-5 Risk Based Continuous DevOps

GAMP-5 Risk Based Continuous DevOps

GAMP-5 Risk Based Continuous DevOps

GAMP-5 Risk Based Continuous DevOps

GAMP-5 Risk Based Continuous DevOps

GAMP-5 Risk Based Continuous DevOps

GAMP-5 Risk Based Continuous DevOps

GAMP-5 Risk Based Continuous DevOps

Recommended

Pharmaceutical Validation

Pharmaceutical Validation

Pharmaceutical Validation

Computer System Validation Training

Computer System Validation Training

Computer System Validation Training

Computer System Validation (CSV) is a core requirement for several industries. The aim of Computer System Validation is to ensure, through documentation, that the computer systems function the way they are intended to, consistently, repeatedly and reproducibly, somewhat in the manner expected of scientific experiments. So, the validation, meaning authentication or corroboration, is something that has to be done right from the start, that is, defining the computer system, to their use and going all the way right up to the time the computer system is retired.

Csv concepts

Computerized system validation_final

Computerized system validation_final

Computerized system validation_finalDuy Tan Geek

Intland Software | codeBeamer ALM: What’s in the Pipeline for the Automotive ...

Intland Software | codeBeamer ALM: What’s in the Pipeline for the Automotive ...

Intland Software | codeBeamer ALM: What’s in the Pipeline for the Automotive ...

Intland Software GmbH

PQS Presentation Final

PQS Presentation Final

PQS Presentation FinalSimba Mavhunga

Computer system validation

Computer system validation

Computer system validation

Payam Khorramshahi

BIS REGISTRATION FOR WEBCAM (FINISHED PRODUCT) – IS 616 : 2017

BIS REGISTRATION FOR WEBCAM (FINISHED PRODUCT) – IS 616 : 2017

BIS REGISTRATION FOR WEBCAM (FINISHED PRODUCT) – IS 616 : 2017

Recommended

Pharmaceutical Validation

Pharmaceutical Validation

Pharmaceutical Validation

Computer System Validation Training

Computer System Validation Training

Computer System Validation Training

Computer System Validation (CSV) is a core requirement for several industries. The aim of Computer System Validation is to ensure, through documentation, that the computer systems function the way they are intended to, consistently, repeatedly and reproducibly, somewhat in the manner expected of scientific experiments. So, the validation, meaning authentication or corroboration, is something that has to be done right from the start, that is, defining the computer system, to their use and going all the way right up to the time the computer system is retired.

Csv concepts

Computerized system validation_final

Computerized system validation_final

Computerized system validation_finalDuy Tan Geek

Intland Software | codeBeamer ALM: What’s in the Pipeline for the Automotive ...

Intland Software | codeBeamer ALM: What’s in the Pipeline for the Automotive ...

Intland Software | codeBeamer ALM: What’s in the Pipeline for the Automotive ...

Intland Software GmbH

PQS Presentation Final

PQS Presentation Final

PQS Presentation FinalSimba Mavhunga

Computer system validation

Computer system validation

Computer system validation

Payam Khorramshahi

BIS REGISTRATION FOR WEBCAM (FINISHED PRODUCT) – IS 616 : 2017

BIS REGISTRATION FOR WEBCAM (FINISHED PRODUCT) – IS 616 : 2017

BIS REGISTRATION FOR WEBCAM (FINISHED PRODUCT) – IS 616 : 2017

Steganography: Hiding your secrets with PHP

Steganography: Hiding your secrets with PHP

Steganography: Hiding your secrets with PHP

Steganography consists of hiding a secret message within another message. Unlike cryptography, steganography tries to achieve security through obscurity, hiding the very presence of the message. Ideally, the steganographic message will look identically to a normal message. This talk examines different techniques to hide messages using steganography from the perspective of a PHP developer. From more classical techniques such as hiding an image within another image using the least significant bits of each pixel, to more advanced ones like using TCP/IP packets.

1 5 equipment-qualification

1 5 equipment-qualification

1 5 equipment-qualificationMalla Reddy College of Pharmacy

unit-1-intro

Docent Education

Quality Risk Management

Quality Risk Management

Quality Risk Management

Gamp Riskbased Approch To Validation

Gamp Riskbased Approch To Validation

Gamp Riskbased Approch To Validation

Rajendra Sadare

Real time release testing

Real time release testing

Real time release testing

GMP EDUCATION : Not for Profit Organization

Medicinal products must comply with their approved specifications before they are released into the market. Compliance with release specifications can be demonstrated by performing a complete set of tests on the active substance and/or finished product, according to the approved specifications. Under certain conditions, an alternative strategy to systematic end product testing is possible. So far this concept has been mainly applied to sterility testing of terminally sterilised products and has become associated with parametric release applications. Recent guidelines adopted in the ICH context (ICH Q8, Q9 and Q10) have made it possible to apply a similar release decision process to tests other than sterility, this approach has been called Real Time Release Testing (RTRT). RTRT is a system of release that gives assurance that the product is of intended quality, based on the information collected during the manufacturing process, through product knowledge and on process understanding and control. RTRT recognises that under specific circumstances an appropriate combination of process controls (critical process parameters) together with pre-defined material attributes may provide greater assurance of product quality than end-product testing and the context as such be an integral part of the control strategy. The RTRT principle is already authorised for use as an optional alternative to routine sterility testing of products terminally sterilised in their final container i.e. parametric release. Enhanced product knowledge and process understanding, the use of quality risk management principles and the application of an appropriate pharmaceutical quality system, as defined within ICH Q8,Q9 and Q10 provide the platform for establishing RTRT mechanisms for other applications, for new products as well as established marketed products. Release of a product can be a combination of a RTR approach for certain critical quality attributes (CQAs) and a more conventional evaluation for other CQAs (partial RTR). This presentation deals with the concepts of Real Time Release Testing. This presentation was compiled from material freely available from FDA , ICH , EMEA and other free resources on the world wide web.

Process Validation for Beginners - FDA - EMA Approach

Process Validation for Beginners - FDA - EMA Approach

Process Validation for Beginners - FDA - EMA Approach

GMP EDUCATION : Not for Profit Organization

In the last year or so the FDA and the EMA have issued new guidance/ draft guidance on "Process Validation".These align process validation activities with a product lifecycle concept and the International Conference on Harmonisation (ICH) guidances for industry, Q8(R2) Pharmaceutical Development, Q9 Quality Risk Management, and Q10 Pharmaceutical Quality System. The earlier guidelines were developed before the elaboration of the new ICH guidelines.With these new guidelines, additional opportunities are available to verify the control of the process by alternative means to the manufacture of traditional process validation batches. The main objective of process validation remains that a process design yields a product meeting its pre-defined quality criteria. ICH Q8, Q9 and Q10 provide a structured way to define product critical quality attributes, design space, the manufacturing process and the control strategy. ICH Q8 refers to an ‘enhanced’ approach to pharmaceutical development which includes an alternative to the traditional process validation. Continuous process verification [see definition in ICH Q8(R2) glossary] can be utilised in process validation protocols for the initial commercial production and for manufacturing process changes for the continual improvement throughout the remainder of the product lifecycle. There is now a new paradigm in process validation. This presentation has been prepared from material available from FDA , EMA and ICH for beginners to have an overview of the new paradigm.

Overview of Computerized Systems Compliance Using the GAMP® 5 Guide

Overview of Computerized Systems Compliance Using the GAMP® 5 Guide

Overview of Computerized Systems Compliance Using the GAMP® 5 Guide

ProPharma Group

New approach to Process Validation 4

New approach to Process Validation 4

New approach to Process Validation 4Santosh Singh

CapaJohn E. Osani

FSMS.pptx

Gmp & c gmp considerations training questionary

Gmp & c gmp considerations training questionary

Gmp & c gmp considerations training questionaryMANEESH KUMAR SINGH

Graphics software standards

Graphics software standards

Graphics software standards

US FDA Process Validation Stage 2 : No. Of Batches Required for Process Perfo...

US FDA Process Validation Stage 2 : No. Of Batches Required for Process Perfo...

US FDA Process Validation Stage 2 : No. Of Batches Required for Process Perfo...GMP EDUCATION : Not for Profit Organization

US FDA - EU Process Validation : Determination of Number of PPQ Batches

US FDA - EU Process Validation : Determination of Number of PPQ Batches

US FDA - EU Process Validation : Determination of Number of PPQ Batches

GMP EDUCATION : Not for Profit Organization

HACCP

Karthika Periyasami

Technical Report.No 90 - Contamination Control Strategy Development in Pharma...

Technical Report.No 90 - Contamination Control Strategy Development in Pharma...

Technical Report.No 90 - Contamination Control Strategy Development in Pharma...

Công ty Cổ phần Tư vấn Thiết kế GMP EU

Gamp 5 overview by jaya prakash ra

Gamp 5 overview by jaya prakash ra

Gamp 5 overview by jaya prakash ra

JAYA PRAKASH VELUCHURI

Traceability Presentation

Traceability Presentation

Traceability Presentation

US FDA Process Validation Stage 3: Continued Process Verification

US FDA Process Validation Stage 3: Continued Process Verification

US FDA Process Validation Stage 3: Continued Process Verification

GMP EDUCATION : Not for Profit Organization

FDA Process Validation Guidance (Guidance for Industry: Process Validation- General Principles and Practices, Jan. 2011) outlines process validation activities in three stages - Stage 1: Process Design, Stage 2: Process Qualification and Stage 3: Continued Process Verification. Completion of Stage 2 subsequent to Stage 1 is a major milestone in the Process Validation Lifecycle as it confirms the process design and demonstrates the expected consistent performance of the manufacturing process. Knowledge and information gained from the design stage through the process qualification stage is used to complete this assessment. Stage 2 demonstrates suitability for successful commercial distribution where the data indicates that the process meets the conditions established in the protocol. Continued Process Verification is initiated for the subsequent commercial batches. Stage 3 assures that the process remains in a state of control during commercial manufacture. This presentation gives a practical approach to implement the stage 3 of the FDA Process Validation Guide.

More Related Content

What's hot

Steganography: Hiding your secrets with PHP

Steganography: Hiding your secrets with PHP

Steganography: Hiding your secrets with PHP

Steganography consists of hiding a secret message within another message. Unlike cryptography, steganography tries to achieve security through obscurity, hiding the very presence of the message. Ideally, the steganographic message will look identically to a normal message. This talk examines different techniques to hide messages using steganography from the perspective of a PHP developer. From more classical techniques such as hiding an image within another image using the least significant bits of each pixel, to more advanced ones like using TCP/IP packets.

1 5 equipment-qualification

1 5 equipment-qualification

1 5 equipment-qualificationMalla Reddy College of Pharmacy

unit-1-intro

Docent Education

Quality Risk Management

Quality Risk Management

Quality Risk Management

Gamp Riskbased Approch To Validation

Gamp Riskbased Approch To Validation

Gamp Riskbased Approch To Validation

Rajendra Sadare

Real time release testing

Real time release testing

Real time release testing

GMP EDUCATION : Not for Profit Organization

Medicinal products must comply with their approved specifications before they are released into the market. Compliance with release specifications can be demonstrated by performing a complete set of tests on the active substance and/or finished product, according to the approved specifications. Under certain conditions, an alternative strategy to systematic end product testing is possible. So far this concept has been mainly applied to sterility testing of terminally sterilised products and has become associated with parametric release applications. Recent guidelines adopted in the ICH context (ICH Q8, Q9 and Q10) have made it possible to apply a similar release decision process to tests other than sterility, this approach has been called Real Time Release Testing (RTRT). RTRT is a system of release that gives assurance that the product is of intended quality, based on the information collected during the manufacturing process, through product knowledge and on process understanding and control. RTRT recognises that under specific circumstances an appropriate combination of process controls (critical process parameters) together with pre-defined material attributes may provide greater assurance of product quality than end-product testing and the context as such be an integral part of the control strategy. The RTRT principle is already authorised for use as an optional alternative to routine sterility testing of products terminally sterilised in their final container i.e. parametric release. Enhanced product knowledge and process understanding, the use of quality risk management principles and the application of an appropriate pharmaceutical quality system, as defined within ICH Q8,Q9 and Q10 provide the platform for establishing RTRT mechanisms for other applications, for new products as well as established marketed products. Release of a product can be a combination of a RTR approach for certain critical quality attributes (CQAs) and a more conventional evaluation for other CQAs (partial RTR). This presentation deals with the concepts of Real Time Release Testing. This presentation was compiled from material freely available from FDA , ICH , EMEA and other free resources on the world wide web.

Process Validation for Beginners - FDA - EMA Approach

Process Validation for Beginners - FDA - EMA Approach

Process Validation for Beginners - FDA - EMA Approach

GMP EDUCATION : Not for Profit Organization

In the last year or so the FDA and the EMA have issued new guidance/ draft guidance on "Process Validation".These align process validation activities with a product lifecycle concept and the International Conference on Harmonisation (ICH) guidances for industry, Q8(R2) Pharmaceutical Development, Q9 Quality Risk Management, and Q10 Pharmaceutical Quality System. The earlier guidelines were developed before the elaboration of the new ICH guidelines.With these new guidelines, additional opportunities are available to verify the control of the process by alternative means to the manufacture of traditional process validation batches. The main objective of process validation remains that a process design yields a product meeting its pre-defined quality criteria. ICH Q8, Q9 and Q10 provide a structured way to define product critical quality attributes, design space, the manufacturing process and the control strategy. ICH Q8 refers to an ‘enhanced’ approach to pharmaceutical development which includes an alternative to the traditional process validation. Continuous process verification [see definition in ICH Q8(R2) glossary] can be utilised in process validation protocols for the initial commercial production and for manufacturing process changes for the continual improvement throughout the remainder of the product lifecycle. There is now a new paradigm in process validation. This presentation has been prepared from material available from FDA , EMA and ICH for beginners to have an overview of the new paradigm.

Overview of Computerized Systems Compliance Using the GAMP® 5 Guide

Overview of Computerized Systems Compliance Using the GAMP® 5 Guide

Overview of Computerized Systems Compliance Using the GAMP® 5 Guide

ProPharma Group

New approach to Process Validation 4

New approach to Process Validation 4

New approach to Process Validation 4Santosh Singh

CapaJohn E. Osani

FSMS.pptx

Gmp & c gmp considerations training questionary

Gmp & c gmp considerations training questionary

Gmp & c gmp considerations training questionaryMANEESH KUMAR SINGH

Graphics software standards

Graphics software standards

Graphics software standards

US FDA Process Validation Stage 2 : No. Of Batches Required for Process Perfo...

US FDA Process Validation Stage 2 : No. Of Batches Required for Process Perfo...

US FDA Process Validation Stage 2 : No. Of Batches Required for Process Perfo...GMP EDUCATION : Not for Profit Organization

US FDA - EU Process Validation : Determination of Number of PPQ Batches

US FDA - EU Process Validation : Determination of Number of PPQ Batches

US FDA - EU Process Validation : Determination of Number of PPQ Batches

GMP EDUCATION : Not for Profit Organization

HACCP

Karthika Periyasami

Technical Report.No 90 - Contamination Control Strategy Development in Pharma...

Technical Report.No 90 - Contamination Control Strategy Development in Pharma...

Technical Report.No 90 - Contamination Control Strategy Development in Pharma...

Công ty Cổ phần Tư vấn Thiết kế GMP EU

Gamp 5 overview by jaya prakash ra

Gamp 5 overview by jaya prakash ra

Gamp 5 overview by jaya prakash ra

JAYA PRAKASH VELUCHURI

Traceability Presentation

Traceability Presentation

Traceability Presentation

US FDA Process Validation Stage 3: Continued Process Verification

US FDA Process Validation Stage 3: Continued Process Verification

US FDA Process Validation Stage 3: Continued Process Verification

GMP EDUCATION : Not for Profit Organization

FDA Process Validation Guidance (Guidance for Industry: Process Validation- General Principles and Practices, Jan. 2011) outlines process validation activities in three stages - Stage 1: Process Design, Stage 2: Process Qualification and Stage 3: Continued Process Verification. Completion of Stage 2 subsequent to Stage 1 is a major milestone in the Process Validation Lifecycle as it confirms the process design and demonstrates the expected consistent performance of the manufacturing process. Knowledge and information gained from the design stage through the process qualification stage is used to complete this assessment. Stage 2 demonstrates suitability for successful commercial distribution where the data indicates that the process meets the conditions established in the protocol. Continued Process Verification is initiated for the subsequent commercial batches. Stage 3 assures that the process remains in a state of control during commercial manufacture. This presentation gives a practical approach to implement the stage 3 of the FDA Process Validation Guide.

What's hot (20)

Steganography: Hiding your secrets with PHP

Steganography: Hiding your secrets with PHP

Steganography: Hiding your secrets with PHP

1 5 equipment-qualification

1 5 equipment-qualification

1 5 equipment-qualification

unit-1-intro

Quality Risk Management

Quality Risk Management

Quality Risk Management

Gamp Riskbased Approch To Validation

Gamp Riskbased Approch To Validation

Gamp Riskbased Approch To Validation

Real time release testing

Real time release testing

Real time release testing

Process Validation for Beginners - FDA - EMA Approach

Process Validation for Beginners - FDA - EMA Approach

Process Validation for Beginners - FDA - EMA Approach

Overview of Computerized Systems Compliance Using the GAMP® 5 Guide

Overview of Computerized Systems Compliance Using the GAMP® 5 Guide

Overview of Computerized Systems Compliance Using the GAMP® 5 Guide

New approach to Process Validation 4

New approach to Process Validation 4

New approach to Process Validation 4

Capa

FSMS.pptx

Gmp & c gmp considerations training questionary

Gmp & c gmp considerations training questionary

Gmp & c gmp considerations training questionary

Graphics software standards

Graphics software standards

Graphics software standards

US FDA Process Validation Stage 2 : No. Of Batches Required for Process Perfo...

US FDA Process Validation Stage 2 : No. Of Batches Required for Process Perfo...

US FDA Process Validation Stage 2 : No. Of Batches Required for Process Perfo...

US FDA - EU Process Validation : Determination of Number of PPQ Batches

US FDA - EU Process Validation : Determination of Number of PPQ Batches

US FDA - EU Process Validation : Determination of Number of PPQ Batches

HACCP

Technical Report.No 90 - Contamination Control Strategy Development in Pharma...

Technical Report.No 90 - Contamination Control Strategy Development in Pharma...

Technical Report.No 90 - Contamination Control Strategy Development in Pharma...

Gamp 5 overview by jaya prakash ra

Gamp 5 overview by jaya prakash ra

Gamp 5 overview by jaya prakash ra

Traceability Presentation

Traceability Presentation

Traceability Presentation

US FDA Process Validation Stage 3: Continued Process Verification

US FDA Process Validation Stage 3: Continued Process Verification

US FDA Process Validation Stage 3: Continued Process Verification

GAMP-5 Risk Based Continuous DevOps

1. GAMP-5 Risk Based Agile Continuous Deployment & Quality Integration An Evolution From Traditional IT Operations Applying the "Good Automated Manufacturing Process" Guidance from Pharma to traditional DevOps SDLS For Agile, Continuous Operations. A Risk Based approach to compliance and readiness. George Georgalis <george@galis.org>